Literature DB >> 31112501

Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.

Harald Hegen1, Janette Walde2, Dejan Milosavljevic3, Fahmy Aboulenein-Djamshidian4, Makbule Senel5, Hayrettin Tumani5,6, Florian Deisenhammer1, Stefan Presslauer7.   

Abstract

Background Free light chains (FLC) have been proposed as diagnostic biomarkers in the cerebrospinal fluid (CSF) of patients with inflammatory central nervous system (CNS) diseases. However, which method to use for determining an intrathecal FLC synthesis has not yet been clarified. The objective of this study was to compare the diagnostic performance of CSF FLC concentration, FLC quotient (QFLC), FLC index and FLC intrathecal fraction (FLCIF). Methods κ- and λ-FLC were measured by nephelometry under blinded conditions in CSF and serum sample pairs of patients with clinically isolated syndrome (CIS; n = 60), multiple sclerosis (MS; n = 60) and other neurological diseases (n = 60) from four different MS centers. QFLC was calculated as the ratio of CSF/serum FLC concentration, the FLC index as QFLC/albumin quotient and the percentage FLCIF by comparing QFLC to a previously empirically determined, albumin quotient-dependent reference limit. Results CSF FLC concentration, QFLC, FLC index and FLCIF of both the κ- and λ-isotype were significantly higher in patients with CIS and MS than in the control group, as well as in oligoclonal bands (OCB) positive than in OCB negative patients. Each parameter was able to identify MS/CIS patients and OCB positivity, however, diagnostic performance determined by receiver operating characteristic (ROC) analyses differed and revealed superiority of FLC index and FLCIF. Conclusions These findings support the diagnostic value of FLC measures that correct for serum FLC levels and albumin quotient, i.e. blood-CSF barrier function.

Entities:  

Keywords:  cerebrospinal fluid; clinically isolated syndrome; free light chain; index; intrathecal fraction; intrathecal synthesis; multiple sclerosis; oligoclonal bands

Mesh:

Substances:

Year:  2019        PMID: 31112501     DOI: 10.1515/cclm-2018-1300

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis-from diagnosis to prediction of disease activity.

Authors:  Harald Hegen; Klaus Berek; Florian Deisenhammer
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 2.  The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Kurt-Wolfram Sühs; Hayrettin Tumani; Marie Süße; Thomas Skripuletz
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

Review 3.  The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.

Authors:  Franz F Konen; Philipp Schwenkenbecher; Ulrich Wurster; Konstantin F Jendretzky; Nora Möhn; Stefan Gingele; Kurt-Wolfram Sühs; Malte J Hannich; Matthias Grothe; Torsten Witte; Martin Stangel; Marie Süße; Thomas Skripuletz
Journal:  J Cent Nerv Syst Dis       Date:  2021-11-19

4.  Intrathecal B cell-related markers for an optimized biological investigation of multiple sclerosis patients.

Authors:  Sawsan Feki; Mariem Damak; Salma Sakka; Yesmine Ben Ali; Sabrina Mejdoub; Nadia Bouattour; Hend Hachicha; Chokri Mhiri; Hatem Masmoudi
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

5.  Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity.

Authors:  Klaus Berek; Gabriel Bsteh; Michael Auer; Franziska Di Pauli; Astrid Grams; Dejan Milosavljevic; Paulina Poskaite; Christine Schnabl; Sebastian Wurth; Anne Zinganell; Thomas Berger; Janette Walde; Florian Deisenhammer; Harald Hegen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.